D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly

European Journal of Endocrinology

Volumn 161, Issue 2, 2009, Pages 231-235

  Kamenicky, Peter ^a,b,c   Dos Santos, Christine ^c   Espinosa, Consuelo ^b   Salenave, Sylvie ^b   Galland, Françoise ^b   Le Bouc, Yves ^c,d,e   Maison, Patrick ^c,f,g   Bougnères, Pierre ^c,h,i   Chanson, Philippe ^a,b,c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b BICÊTRE HOSPITAL   (France)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e ARMAND TROUSSEAU HOSPITAL   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^h Service de Pharmacologie Clinique ^*  (France)

ⁱ UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE RECEPTOR; SOMATOMEDIN C; CARRIER PROTEIN; DNA; HUMAN GROWTH HORMONE; SOMATOTROPIN BINDING PROTEIN; SOMATOTROPIN-BINDING PROTEIN;

ACROMEGALY; ADENOMA; ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; BIOCHEMISTRY; BODY HEIGHT; BODY MASS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; EXON; FEMALE; GENE DELETION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DETERMINATION; AGED; BLOOD; CHEMISTRY; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; STATISTICAL MODEL;

ACROMEGALY; ADULT; AGED; CARRIER PROTEINS; DNA; FEMALE; GENOTYPE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LINEAR MODELS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 68349145046     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0053     Document Type: Article

References (29)

1. Melmed S. Medical progress: acromegaly. New England Journal of Medicine 2006 355 2558-2573.
2. Parkinson C, Ryder WD & Trainer PJ. The relationship between serum GH and serum IGF-I in acromegaly is gender-specific. Journal of Clinical Endocrinology and Metabolism 2001 86 5240-5244. (Pubitemid 33070242)
3. Dobrashian RD, O'Halloran DJ, Hunt A, Beardwell CG & Shalet SM. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly. Clinical Endocrinology 1993 38 589-593. (Pubitemid 23168472)
4. Dimaraki EV, Jaffe CA, DeMott-Friberg R, Chandler WF & Barkan AL. Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. Journal of Clinical Endocrinology and Metabolism 2002 87 3537-3542.
5. Freda PU, Nuruzzaman AT, Reyes CM, Sundeen RE & Post KD. Significance of 'abnormal' nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. Journal of Clinical Endocrinology and Metabolism 2004 89 495-500.
6. Alexopoulou O, Bex M, Abs R, T'Sjoen G, Velkeniers B & Maiter D. Divergence between growth hormone and insulin-like growth factor-I concentrations in the follow-up of acromegaly. Journal of Clinical Endocrinology and Metabolism 2008 93 1324-1330.
7. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL & Thorner MO. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. Journal of Clinical Endocrinology and Metabolism 1987 64 51-58.
8. Barkan AL, Halasz I, Dornfeld KJ, Jaffe CA, Friberg RD, Chandler WF & Sandler HM. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 1997 82 3187-3191. (Pubitemid 27419054)
9. Pantel J, Machinis K, Sobrier ML, Duquesnoy P, Goossens M & Amselem S. Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. Journal of Biological Chemistry 2000 275 18664-18669.
10. Schmid C, Krayenbuehl PA, Bernays RL, Zwimpfer C, Maly FE & Wiesli P. Growth hormone (GH) receptor isoform in acromegaly: lower concentrations of GH but not insulin-like growth factor-1 in patients with a genomic deletion of exon 3 in the GH receptor gene. Clinical Chemistry 2007 53 1484-1488. (Pubitemid 47206345)
11. Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V & Bougneres P. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nature Genetics 2004 36 720-724. (Pubitemid 38886633)
12. Binder G, Baur F, Schweizer R & Ranke MB. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-forgestational- age children. Journal of Clinical Endocrinology and Metabolism 2006 91 659-664. (Pubitemid 43236940)
13. Jorge AA, Marchisotti FG, Montenegro LR, Carvalho LR, Mendonca BB & Arnhold IJ. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency. Journal of Clinical Endocrinology and Metabolism 2006 91 1076-1080.
14. Raz B, Janner M, Petkovic V, Lochmatter D, Eble A, Dattani MT, Hindmarsh PC, Fluck CE & Mullis PE. Influence of growth hormone (GH) receptor deletion of exon 3 and full-length isoforms on GH response and final height in patients with severe GH deficiency. Journal of Clinical Endocrinology and Metabolism 2008 93 974-980.
15. van der Klaauw AA, van der Straaten T, Baak-Pablo R, Biermasz NR, Guchelaar HJ, Pereira AM, Smit JW & Romijn JA. Influence of the d3-growth hormone receptor isoform on shortterm and long-term treatment response to growth hormone replacement in growth hormone deficient adults. Journal of Clinical Endocrinology and Metabolism 2008 93 2828-2834. (Pubitemid 352008558)
16. Bougneres P & Goffin V. The growth hormone receptor in growth. Endocrinology and Metabolism Clinics of North America 2007 36 1-16
17. Blum WF, Crowe BJ, Quigley CA, Jung H, Cao D, Ross JL, Braun L & Rappold G. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: two-year results of a randomized, controlled, multicenter trial. Journal of Clinical Endocrinology and Metabolism 2007 92 219-228. (Pubitemid 46067535)
18. Pilotta A, Mella P, Filisetti M, Felappi B, Prandi E, Parrinello G, Notarangelo LD & Buzi F. Common polymorphisms of the growth hormone (GH) receptor do not correlate with the growth response to exogenous recombinant human GH in GH-deficient children. Journal of Clinical Endocrinology and Metabolism 2006 91 1178-1180. (Pubitemid 43357798)
19. Carrascosa A, Esteban C, Espadero R, Fernandez-Cancio M, Andaluz P, Clemente M, Audi L, Wollmann H, Fryklund L & Parodi L. The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for- gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients. Journal of Clinical Endocrinology and Metabolism 2006 91 3281-3286. (Pubitemid 44402092)
20. Carrascosa A, Audi L, Esteban C, Fernandez-Cancio M, Andaluz P, Gussinye M, Clemente M, Yeste D & Albisu MA. Growth hormone (GH) dose, but not exon 3-deleted/full-length GH receptor polymorphism genotypes, influences growth response to twoyear GH therapy in short small-for-gestational-age children. Journal of Clinical Endocrinology and Metabolism 2008 93 147-153.
21. Jensen RB, Vielwerth S, Larsen T, Greisen G, Leffers H & Juul A. The presence of the d3-growth hormone receptor polymorphism is negatively associated with fetal growth but positively associated with postnatal growth in healthy subjects. Journal of Clinical Endocrinology and Metabolism 2007 92 2758-2763. (Pubitemid 47037387)
22. Kenth G, Shao Z, Cole DE & Goodyer CG. Relationship of the human growth hormone receptor exon 3 genotype with final adult height and bone mineral density. Journal of Clinical Endocrinology and Metabolism 2007 92 725-728. (Pubitemid 46255321)
23. Mercado M, Gonzalez B, Sandoval C, Esquenazi Y, Mier F, Vargas G, de los Monteros AL & Sosa E. Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly. Journal of Clinical Endocrinology and Metabolism 2008 93 3411-3415.
24. Galland F, Kamenicky P, Affres H, Reznik Y, Pontvert D, Le Bouc Y, Young J & Chanson P. McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patients. Journal of Clinical Endocrinology and Metabolism 2006 91 4957-4961. (Pubitemid 44917334)
25. Audi L, Esteban C, Carrascosa A, Espadero R, Perez-Arroyo A, Arjona R, Clemente M,Wollmann H, Fryklund L & Parodi LA. Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n = 247) and in an adult control population (n = 289) show increased fl/fl in short SGA. Journal of Clinical Endocrinology and Metabolism 2006 91 5038-5043. (Pubitemid 44917347)
26. Leung KC, Johannsson G, Leong GM & Ho KK. Estrogen regulation of growth hormone action. Endocrine Reviews 2004 25 693-721. (Pubitemid 39366048)
27. Freda PU, Shen W, Heymsfield SB, Reyes-Vidal CM, Geer EB, Bruce JN & Gallagher D. Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with GH, IGF-I excess due to acromegaly. Journal of Clinical Endocrinology and Metabolism 2008 93 2334-2343.
28. O'Sullivan AJ, Kelly JJ, Hoffman DM, Freund J & Ho KK. Body composition and energy expenditure in acromegaly. Journal of Clinical Endocrinology and Metabolism 1994 78 381-386. (Pubitemid 24061757)
29. Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A & Rosenfeld RG. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults. Endocrinology and Metabolism 2001 86 3001-3008. (Pubitemid 32673456)